IDYA
Price
$17.82
Change
-$0.36 (-1.98%)
Updated
May 9, 02:28 PM (EDT)
Capitalization
1.56B
95 days until earnings call
THTX
Price
$2.61
Change
-$0.13 (-4.74%)
Updated
May 9, 04:59 PM (EDT)
Capitalization
127.21M
Ad is loading...

IDYA vs THTX

Header iconIDYA vs THTX Comparison
Open Charts IDYA vs THTXBanner chart's image
IDEAYA Biosciences
Price$17.82
Change-$0.36 (-1.98%)
Volume$100
Capitalization1.56B
Theratechnologies
Price$2.61
Change-$0.13 (-4.74%)
Volume$5.56K
Capitalization127.21M
IDYA vs THTX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. THTX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and THTX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (IDYA: $18.18 vs. THTX: $2.74)
Brand notoriety: IDYA and THTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 114% vs. THTX: 7%
Market capitalization -- IDYA: $1.56B vs. THTX: $127.21M
IDYA [@Biotechnology] is valued at $1.56B. THTX’s [@Biotechnology] market capitalization is $127.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileTHTX’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • THTX’s FA Score: 1 green, 4 red.
According to our system of comparison, THTX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while THTX’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 5 bearish.
  • THTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than THTX.

Price Growth

IDYA (@Biotechnology) experienced а -11.19% price change this week, while THTX (@Biotechnology) price change was -6.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.32%. For the same industry, the average monthly price growth was +9.54%, and the average quarterly price growth was -14.72%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

THTX is expected to report earnings on Apr 09, 2025.

Industries' Descriptions

@Biotechnology (-6.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.56B) has a higher market cap than THTX($127M). THTX YTD gains are higher at: 51.381 vs. IDYA (-29.261). THTX has higher annual earnings (EBITDA): 10.1M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. THTX (4.34M). IDYA has less debt than THTX: IDYA (19.2M) vs THTX (50.4M). THTX has higher revenues than IDYA: THTX (88.7M) vs IDYA (7M).
IDYATHTXIDYA / THTX
Capitalization1.56B127M1,230%
EBITDA-323.14M10.1M-3,199%
Gain YTD-29.26151.381-57%
P/E RatioN/AN/A-
Revenue7M88.7M8%
Total Cash676M4.34M15,576%
Total Debt19.2M50.4M38%
FUNDAMENTALS RATINGS
IDYA vs THTX: Fundamental Ratings
IDYA
THTX
OUTLOOK RATING
1..100
1789
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
49100
PRICE GROWTH RATING
1..100
6334
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (61) in the null industry is somewhat better than the same rating for THTX (100). This means that IDYA’s stock grew somewhat faster than THTX’s over the last 12 months.

IDYA's Profit vs Risk Rating (64) in the null industry is somewhat better than the same rating for THTX (100). This means that IDYA’s stock grew somewhat faster than THTX’s over the last 12 months.

IDYA's SMR Rating (49) in the null industry is somewhat better than the same rating for THTX (100). This means that IDYA’s stock grew somewhat faster than THTX’s over the last 12 months.

THTX's Price Growth Rating (34) in the null industry is in the same range as IDYA (63). This means that THTX’s stock grew similarly to IDYA’s over the last 12 months.

THTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for IDYA (100). This means that THTX’s stock grew significantly faster than IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYATHTX
RSI
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PCEMX13.78N/A
N/A
PACE International Em Mkts Eq P
GSROX12.68N/A
N/A
Goldman Sachs Small Cap Gr Insghts R
GTHIX35.99N/A
N/A
Invesco Health Care Invstor
WGROX81.09N/A
N/A
Wasatch Core Growth
TISAX61.49N/A
N/A
Nuveen S&P 500 Index I

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with RCKT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.96%
RCKT - IDYA
58%
Loosely correlated
+11.57%
IMNM - IDYA
56%
Loosely correlated
+3.77%
NTLA - IDYA
55%
Loosely correlated
+13.58%
KRYS - IDYA
55%
Loosely correlated
+0.27%
XENE - IDYA
54%
Loosely correlated
+0.59%
More

THTX and

Correlation & Price change

A.I.dvisor tells us that THTX and IDYA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and IDYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
N/A
IDYA - THTX
27%
Poorly correlated
+1.96%
GNPX - THTX
27%
Poorly correlated
+2.46%
SCPH - THTX
27%
Poorly correlated
+4.15%
CSLLY - THTX
26%
Poorly correlated
-1.60%
THRD - THTX
26%
Poorly correlated
+0.19%
More